Thursday, March 26, 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 389 (TSX: $TGOD.TO) (OTC: $TGODF), (TSXV: $NRTH.V) (TSX: $ALEF.TO) (OTC: $ALEAF)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 389 (TSX: $TGOD.TO) (OTC: $TGODF), (TSXV: $NRTH.V) (TSX: $ALEF.TO) (OTC: $ALEAF)
Delta, Kelowna, BC, March 26, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/03261TGOD-NRTH-ALEF.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we are looking at a few company announcements.
Starting with, Cannalogue, who has submitted an application to Health Canada to conduct a real-world clinical trial with medical cannabis for COVID-19 (Coronavirus). If approved by Health Canada, Cannalogue will enroll patients into the research study to determine if medical cannabis can reduce the symptoms caused by COVID-19 or any mutant strains of coronavirus.
"Cannalogue is committed to doing our part. The need is too great and we have to act now," says Dr. Mohan Cooray, President and CEO of Cannalogue. Dr. Cooray, who is also a specialist in Internal Medicine, Gastroenterology, and Hepatology goes on to say, "We are not suggesting with the current knowledge of medical cannabis that it is a prevention, treatment or cure for COVID-19 or coronaviruses. However, plant cannabinoids have naturally occurring immunomodulatory properties that absolutely require expedited investigation given the current global COVID-19 pandemic," he says.
Cannalogue is responding to the call by the Honourable Prime Minister of Canada to enforce wartime measures and for all Canadian businesses to stand united in the fight against COVID-19. The specialists at Cannalogue believe the active medical ingredients from the cannabis plant could potentially boost the immune system to reduce the severity of symptoms from COVID-19.
"Cannabinoid receptors are naturally found on immune cells in the body. If stimulated prior to an infection, it may dampen the inflammatory response that follows, which is a key factor in the severity of symptoms observed in patients," says Dr. Cooray. "This appears to be a common mechanism of action for the current therapies being investigated for COVID-19 research studies. If we can't flatten the curve, then we need to focus on reducing the number of deaths," he says.
In support of the medical cannabis sector and scientific research community, Cannalogue will be releasing an exclusive insider health report that reveals key medical insights on emerging therapeutic areas with respect to medical cannabis.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), announced that, due to market conditions, it is adapting operations and aggressively reducing costs.
The Company has postponed the start up of its Valleyfield facility in order to centralize cultivation operations at Ancaster. The Ontario facility is able to produce larger volumes than initially anticipated, enabling the Company to delay cultivation operations in Valleyfield saving costs and capital. The Company has temporarily laid off the majority of its Valleyfield employees and intends to restart operations there later in the year. Ancaster is not impacted and continues to grow and harvest premium organic cannabis for the recreational and medical markets.
This change does not impact TGOD's timeline for the launch of its remaining Cannabis 2.0 products, with Infusers already launched and organic teas and vapes still on track to become available at the end of next month.
TGOD expects to imminently receive its licence amendment from Health Canada for the processing facility at Ancaster. Once it is received, the Company will be able to automate many of its processes reducing costs and further accelerating production.
As it continues to work towards becoming EBITDA and operating cash flow positive later this year, beyond the cost savings generated with the Valleyfield operation postponement, TGOD has undertaken another series of measures to aggressively reduce costs. This includes:
- Temporary salary reductions of 20% for salaried employees and 30% for certain executives
- A freeze on all non-essential recruitment and consultancy work
- Working with suppliers to identify further cost savings and efficiencies
"Multiple factors, most particularly the COVID-19 pandemic, are contributing to an environment in which we must be extremely prudent with how we manage our cost structure. These are unprecedented times, and the situation continues to evolve. With the support and unity I have seen from our employees, partners and stakeholders, I am very confident that TGOD can tackle this challenge and come out much stronger," commented Brian Athaide, CEO of TGOD. "We have seen very strong consumer and medical patient feedback from our recent TGOD Infusers launch and are looking forward to having them available in more stores quickly. These along with our upcoming additional 2.0 products are very unique and deliver superior consumer experiences which will help further differentiate and build our TGOD organic brand positioning," continued Athaide.
48North Cannabis Corp. (TSXV:NRTH), announced that it has shipped the first order of its vape product Avitas to the Ontario Cannabis Store for retail sale. The Avitas vape marks the Company's first vape product available for sale.
Avitas, available in over 500 stores in Washington, Oregon and Colorado is one of the best-selling single strain vaporizer cartridges in the United States and represents 48North's first product introduction as part of its vaporizer strategy. Avitas develops 100% additive free, single strain, ultra-refined and purified, vaporizer cartridges. Single strain vaporizer cartridges represent the fastest-growing, next-generation cannabis product category in the United States.
To start, 48North will be launching a Super Citrus Haze vaporizer cartridge, using flower that has been hand selected for flavor, aroma and cannabinoid profile. This unique sativa forward strain is earthy and citrusy to the tongue with terpenes that evoke herbs like black pepper and cloves. The Company uses a gentle extraction method to preserve the flower's cannabinoid and terpene profiles, resulting in single strain, full spectrum oils – clean and simple.
Successfully launching the company's first vape product to market is indicative of 48North's renewed commitment to improving operations, investing in product design, and supporting high-quality experiences for Canadian consumers.
"Since the beginning, 48North has been committed to selling next-generation cannabis products to Canadian consumers. In response, the company has built landmark partnerships with brands like Apothecanna and Avitas to bring some of the highest-quality products to consumers. Bringing market-tested brands from the United States to Canada has been part of the 48North strategy from the beginning. In doing so, we capitalize on a head-start with brand building and fostering consumer loyality. We very excited to share this product with Canadians across the country," said Kirsten Gauthier, CMO of 48North.
Aleafia Health Inc. (TSX: ALEF) (OTC: ALEAF) announced launching its last-mile medical cannabis home delivery service. It will provide patients next-day, direct-to-home delivery on medical cannabis orders made in Ontario’s Greater Golden Horseshoe Region, home to over 9 million people.
By delivering directly to patients’ homes, the service provides safe, contactless delivery, eliminating the need for customers to pick-up products at post offices and post boxes. It also mitigates the risk to the Company of disruption of postal and third-party parcel delivery services during the COVID-19 pandemic.
The initial GGHR launch is anticipated to occur during the next two weeks, with a planned subsequent expansion to new Canadian markets, and the introduction of same-day, scheduled delivery.
“By controlling the last mile of our supply chain, we are providing a unique service to patients who want fast, secure and convenient access to their medicine,” said Aleafia Health CEO Geoffrey Benic. “Adapting to this challenging environment is critical. In addition to launching home delivery, earlier this month we transitioned to conducting 100 per cent of patient consultations remotely through telemedicine, with the goal of not missing a single patient appointment.
“Having said that, introducing home delivery has been long in the works and will be a permanent feature that we offer moving forwards.”
Aleafia Health’s home delivery benefits from the supply chain logistics experience of Benic and COO Greg Rossi, who were among the founding partners of the award winning online grocery fulfillment and delivery service, GroceryGateway.com. The pair have also worked as executive consultants on supply chain logistics projects for some of the world’s largest companies including Walmart Inc., Nestlé S.A., Kraft Heinz Company, Campbell Soup Company and Mondelez International. Benic and Rossi were also the architects of Trust Delivery, the first and only same-day Canadian medical cannabis delivery service.
Now lastly we look at two stories linking the alcohol industry with the cannabis sector, and how the alcohol industry is now adopting methods from the cannabis sector as their roles in society are reversed.
One company, Boozer Inc. announced the launch of a Canada-wide click-and-collect initiative in response to the continuing COVID-19 public health challenge. Complementing our existing same-day delivery platform, the click-and-collect feature will allow Canadian alcohol retailers, including independent retailers, craft breweries and distilleries, to stay open for business using the Boozer e-commerce platform for 'take-out' and 'delivery'.
The click-and-collect service will allow age-permitted users to order their favourite alcoholic beverages and products for on-demand pickup from a licensed retail location near them, all through the existing Boozer platform. Employing an e-commerce solution allows both the customers and retail staff to maintain social distancing to the extent they feel comfortable, or as required by local authorities. "Retailers now more than ever need to provide a safe environment for consumers to purchase products. Today retailers are effectively needing to turn in-store shoppable retail spaces into click-and-collect and delivery fulfillment centers.
We are looking to support this activity by moving forward with this initiative that will keep local retail stores open and to provide much needed assistance to the retail sector," commented Michael Kniazeff, CEO and Co-Founder of Boozer.
"Click-and-collect is well adopted by consumers in the grocery and restaurant industries, and we're excited to bring this convenient experience to the retail alcohol space," commented Ian Delves, President and Co-Founder of Boozer. "On the delivery front, like others Boozer has been seeing massive spikes in demand over the past week. We see the launch of click-and-collect as a way to help alleviate some of the strain the entire delivery community has been dealing with, as we navigate this unprecedented lift in orders," he added.
The National Association of Cannabis Businesses (NACB) today announced the appointment of Mark Gorman as its new Executive Vice President and Chief Operating Officer. The NACB is the only cannabis industry trade group dedicated to promoting national standards for responsible advertising and marketing of cannabis products, as well as other best practice guidelines for businesses in the burgeoning sector.
Gorman joins NACB from the Distilled Spirits Council of the United States (DISCUS), where he served 20 years as the Senior Vice President for Government Relations overseeing the distilled spirits industry’s highly successful legislative, public policy and advocacy activities at both the federal and state levels.
“We are delighted to have Mark join our team as the leader of our governmental policy and outreach efforts,” said Gina Kranwinkel, NACB’s President and CEO. “Mark’s depth of experience with the challenges faced by highly regulated industries make him an ideal fit with our organization.”
Under Gorman’s direction, the NACB will work to broaden support among other cannabis groups, consumer protection agencies and government policy makers for its responsibility standards and best practice guidance.
“The distilled spirits industry weaves responsibility into every facet of its business from advertising and marketing practices to public policy and education initiatives. This commitment to responsibility has earned the industry respect on Capitol Hill and credibility in state capitols across the country. I look forward to applying this experience to help the NACB develop a successful legislative and regulatory path forward,” Gorman said.
Prior to joining DISCUS, Mark spent seven years leading government affairs at the National Restaurant Association and several years as deputy director at the Washington office of General Mills, Inc. He is also a Capitol Hill veteran having worked six years as a tax legislative assistant for Sen. John H. Chafee (R-RI).
The NACB, which was established in 2017, represents over 400 member-businesses and thousands of cannabis professionals around the country. They are the industry’s first and only self-regulatory organization, whose mission is to support the compliance, transparency and growth of legal cannabis businesses in the U.S.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800 665 0411
Tuesday, March 24, 2020
Investorideas.com - Cannabis Stock News: Village Farms International (TSX: $VFF.TO) (NASDAQ: $VFF) Completes $11.5 Million Public Offering of Common Shares, Including Exercise of Over-Allotment Option
Investorideas.com - Cannabis Stock News: Village Farms International (TSX: $VFF.TO) (NASDAQ: $VFF) Completes $11.5 Million Public Offering of Common Shares, Including Exercise of Over-Allotment Option
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 388 - Cannabis Deemed Essential (CSE: $SHRM.C)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 388 - Cannabis Deemed Essential (CSE: $SHRM.C)
Delta, Kelowna, BC, March 24, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we are looking at how the COVID-19 Pandemic has pushed cannabis fully away from fringe to “essential” and how psilocybin could be next.
A recent Forbes article discussed how, “In state after state, governors and public health officials are deeming cannabis businesses “essential” operations that can stay open amid coronavirus-related forced closures and stay-at-home mandates. People might not be able to go bowling or see a movie in theaters, but they can still stock up on marijuana.”
The article continues to discuss which states have declared cannabis essential, such as California, and how even some states where cannabis business was still being scrutinized heavily have even allowed the continuation of medical and recreational cannabis operations.
In Canada, in recent news, “Ontario Premier Doug Ford announced Monday that all non-essential businesses in the province will be required to shut down effective Tuesday at 11:59 p.m. for a period of at least 14 days. A list of businesses that will remain open will be released Tuesday, the government said in a release.”
The article continued saying that, “Licensed cannabis stores will remain open in Ontario during a provincial emergency shutdown of non-essential businesses designed to limit the spread of COVID-19, according to two sources directly familiar with the matter.”
Now as cannabis pushes from recreational pass-time or fringe medication to “essential” medication in North America, this is driving the push for another fringe drug with massive potential, psilocybin.
There has been a meme floating around the internet as of late during the COVID-19 Pandemic (image below), and while this may seem silly to some, many are taking this opportunity to push local governments into reconsidering magic mushrooms.
In other recent news from California, “a campaign to legalize psilocybin mushrooms in California is asking the state to allow online signature gathering for their ballot petition, arguing that the coronavirus outbreak necessitates an alternative means to put the psychedelic reform measure before voters in November.”
Decriminalize California, the group behind the proposed initiative, partnered with two other campaigns in the state to write a letter to the governor, secretary of state and attorney general, requesting the emergency policy change. It’s the latest in a series of similar requests from drug policy reform campaigns across the U.S., with activists scrambling to qualify their measures for state ballots amid the pandemic.
In news from Hawaii, “Two members of the Hawaii Legislature introduced a set of resolutions aimed at studying the medicinal applications of psilocybin in order to develop a plan that ensures the availability of the compound for adult patients in the state.”
This leads to companies like Champignon Brands Inc. (CSE: SHRM), a health and wellness company specializing in the formulation of a suite of medicinal mushrooms and mushroom-infused products, who recently introduced new proprietary intellectual property into its vertically integrated alternative medicine product range. The Company announced its entry into a definitive agreement, signed March 18, 2020, to acquire Novo Formulations Ltd.
Novoformulations’ novel delivery system platforms, as well as complementary R&D advancements, will accelerate the architecture of Champignon’s patent portfolio as the Company persists in being a first mover in the existing consumer package goods and emerging psychedelic medicine arenas.
Novoformulations is a specialty biotechnology company focused on developing novel and innovative delivery systems for the pharmaceutical and nutraceutical industries. The Novoformulations team consists of a roster of PhDs and technician level scientists, each with decades of experience building novel defensible medical IP, as well as subsequently developing and commercially marketing proprietary delivery platforms.
Novoformulations is presently working with ketamine, anaesthetics and adaptogenics, as well as a host of pharmaceuticals and natural molecules at a purpose-built GMP and pharmaceutical (DIN) licensed facility located in Quebec, Canada, and an accredited pharmacy in Ontario. There, the Company is actively formulating, developing and commercializing bioavailable delivery platforms, including:
● Transdermal (topical);
● Intranasal;
● Sublingual; and,
● Novel oral and suppository.
Also based in Quebec, Novoformulations’ manufacturing partner will process its novel delivery platforms and formulations into marketable end products at its 40,000-square-foot GMP-certified, Health Canada and Federal Drug Administration (FDA)-approved manufacturing facility.
Champignon plans to leverage Novoformulations’ existing product development infrastructure and licensed affiliates to pursue psilocybin and MDMA based formulations, with the objective of developing and commercializing rapid onset treatments capable of improving health outcomes, including Depression, PTSD and substance and alcohol use disorders (DPS). The current marketplace for pharmacologic DPS treatments in North America exceeds $10 billion annually.1
“The recent acquisitions of Novoformulations and Artisan Growers are absolutely accretive to each other and to our stated business objectives of enhancing the health and wellbeing of millions of consumers via our suite of medicinal mushroom extracts, mushroom-infused products and now novel delivery systems,” Champignon Chief Executive Officer Gareth Birdsall commented.
“The existing infrastructure inherited from these recent acquisitions positions us as a leading participant throughout the entire alternative medicine lifecycle, from R&D to formulation, manufacturing and end distribution. The end result will be a turnkey solution that incorporates both standardized ingredient mixtures and pharmaceutical grade products that can now be marketed via a variety of proprietary delivery systems,” continued Gareth Birdsall. “The addition of Novoformulations allows Champignon to deliver medications in a safer, more effective and more expeditious manner than our peers, from bench top in the laboratory, to preclinical and clinical trials. We are intent on the commercialization of products throughout North America, as rapidly as is safely and effectively practicable."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800 665 0411
Subscribe to:
Posts (Atom)